Munich Personal RePEc Archive
metadata only
The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry
The Janssen-Cilag proposal for a risk-sharing agreement regarding bortezomib received a welcome signal from NICE. The Office of Fair Trading report included risk-sharing agreements as an available tool for the National Health Service. Nonetheless, recent discussions have somewhat neglected the econo
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- La investigación tecnológica médica: apoyo a la cooperación entre países#285569
- An Economic Analysis of Liability for AIDS-Contaminated Blood Products#1020016
- Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use.#25754
- A Defence of Pharmaceutical Paternalism#772508
- Why high-risk, non-expected-utility-maximising gambles can be rational and beneficial: the case of HIV cure studies#703766
Record · ID 1278080
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive